Sweden Mycoplasma Testing Market Size & Outlook, 2023-2030

The mycoplasma testing market in Sweden is expected to reach a projected revenue of US$ 21.5 million by 2030. A compound annual growth rate of 12.7% is expected of Sweden mycoplasma testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$9.3
Forecast, 2030 (US$M)
$21.5
CAGR, 2024 - 2030
12.7%
Report Coverage
Sweden

Sweden mycoplasma testing market highlights

  • The Sweden mycoplasma testing market generated a revenue of USD 9.3 million in 2023 and is expected to reach USD 21.5 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Mycoplasma testing market data book summary

Market revenue in 2023USD 9.3 million
Market revenue in 2030USD 21.5 million
Growth rate12.7% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Kits & Reagents, Services
Key market players worldwideThermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen


Other key industry trends

  • In terms of revenue, Sweden accounted for 1.0% of the global mycoplasma testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK mycoplasma testing market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 142.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mycoplasma Testing Market Scope

Mycoplasma testing market segmentation & scope
Instruments
PCR Assays
Nucleic Acid Detection Kits
Stains
Elimination Kits
Standards & Controls
Others Kits & Reagents
Services
PCR
ELISA
Direct Assay
Indirect Assay
Microbial Culture Techniques
Enzymatic Methods
Cell Line Testing
Virus Testing
End of Production Cells Testing
Other Applications
Pharmaceutical & Biotechnology Companies
Cell Banks
Contract Research Organizations
Academic & Research Institutes
Others End Use

Mycoplasma Testing Market Companies

Name Profile # Employees HQ Website

Sweden mycoplasma testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.


Kits & reagents was the largest segment with a revenue share of 58.06% in 2023. Horizon Databook has segmented the Sweden mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.


The country is expected to witness significant growth due to several factors, such as the growing biopharmaceutical industry, advanced infrastructure, & supportive government initiatives. Furthermore, Sweden has a strong R&D focus on scientific innovation and is home to leading academic institutions & research organizations. As of December 2023, Sweden has more than 300 drugs in active development within its pharmaceutical R&D pipeline.

This placed Sweden fifth in Europe for the number of drugs under development, which is a notable achievement, especially considering the economic size of the traditional EU5 countries. When combined with its Nordic neighbors, the region is surpassed only by the UK and Switzerland. In addition, Sweden boasts one of the highest percentages of preclinical-stage drug candidates among its peers.

However, these candidates face higher risks of not progressing to approved drugs for patients. As more drugs progress through development stages, ensuring the purity of cell cultures becomes crucial, necessitating rigorous mycoplasma testing. Innovations in testing methods will likely emerge, offering faster and more cost-effective solutions to meet the growing needs of the pharmaceutical industry.

Reasons to subscribe to Sweden mycoplasma testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden mycoplasma testing market databook

  • Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden mycoplasma testing market size, by product, 2018-2030 (US$M)

Sweden Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)

Sweden mycoplasma testing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more